Key result
New-onset atrial arrhythmias after lung transplantation increased all-cause mortality, with a hazard ratio of 2.80 (95% CI 1.62-4.84; P<.001) in patients with right heart structural abnormalities.
Why the study?
The role of preoperative right heart structural abnormalities in driving new-onset atrial arrhythmias after lung transplantation and modifying their prognostic impact on mortality was unclear.
Do preoperative right heart structural abnormalities drive new-onset atrial arrhythmias or modify their effect on all-cause mortality in adult lung transplant recipients?
Cohort (n=503)
Yes
Do preoperative right heart structural abnormalities drive new-onset atrial arrhythmias or modify their effect on all-cause mortality in adult lung transplant recipients?
Postoperative atrial arrhythmias following lung transplantation are primarily driven by age and left ventricular hypertrophy rather than preoperative right heart structural abnormalities, though right heart phenotype may still modify long-term mortality risk.
Objective To determine whether preoperative right heart structural abnormalities (RHSA) drive new-onset atrial arrhythmias (AA) after lung transplantation and modify the prognostic impact of AA on all-cause mortality. Methods In this dual-center retrospective cohort, 503 adult recipients who underwent allogeneic lung transplantation between 2017 and 2024 were stratified by preoperative echocardiography into RHSA and non-RHSA groups. The primary exposure was new-onset AA within 30 postoperative days; the primary outcome was all-cause mortality. Firth-corrected penalized logistic regression on 50 multiply imputed datasets identified independent risk factors for AA. A multivariable Cox model with an RHSA × AA interaction term assessed effect modification by right heart phenotype. Results Postoperative AA occurred in 30.2% of recipients and was independently predicted by recipient age and left ventricular hypertrophy (LVH), whereas RHSA was not an independent risk factor. The AA-associated hazard of all-cause mortality was numerically greater in the RHSA subgroup (HR, 2.80; 95% CI, 1.62–4.84; P <.001) than in the non-RHSA subgroup (HR, 1.55; 95% CI, 1.14–2.10; P=.005); the RHSA × AA interaction term was not statistically significant (P = .158). Conclusions Postoperative AA is driven predominantly by age and LVH, not by RHSA. Effect modification by RHSA was not formally established in this cohort, although RHSA may be a potential effect modifier. These findings are hypothesis-generating; a right heart phenotype-based rhythm-control strategy requires prospective validation.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) conducted a cohort in Lung transplantation (n=503). New-onset atrial arrhythmias within 30 postoperative days vs. No new-onset atrial arrhythmias was evaluated on All-cause mortality (HR 2.80, 95% CI 1.62-4.84, p=<.001). New-onset atrial arrhythmias after lung transplantation increased all-cause mortality, with a hazard ratio of 2.80 (95% CI 1.62-4.84; P<.001) in patients with right heart structural abnormalities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: